| Literature DB >> 33010803 |
Bjoern Grosse1, Stefan Eberbach2, Hans O Pinnschmidt3, Deirdre Vincent4, Martin Schmidt-Niemann2, Konrad Reinshagen2,4.
Abstract
BACKGROUND: Ilioinguinal-iliohypogastric block (ILIHB) is a well-established procedure for postoperative analgesia after open inguinal surgery in children. This procedure is effective and safe, especially when ultrasound is used. Data availability for comparing ultrasound-guided blocks versus wound infiltration is still weak. The study was designed to determine the efficacy of ultrasound-guided ILIHB (US-ILIHB) on postoperative pain control in pediatric patients following a inguinal daycase surgery, compared with perifocal wound infiltration (PWI) by the surgeon.Entities:
Keywords: Age; Ambulatory, local; Anesthetics; Drugs, infant; Pain, outpatient; Regional; Ultrasound, opioids
Year: 2020 PMID: 33010803 PMCID: PMC7532635 DOI: 10.1186/s12871-020-01170-z
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Fig. 1Anatomy: a macroscopic: Black arrows = ilioinguinal-iliohypogastric nerves; b Ultrasound image: EO = abdominal external oblique muscle, IO = abdominal internal oblique muscle, TA = transverse abdominal muscle; White arrows = Ilioinguinal and iliohypogastric nerves between fasciae, Dotted line = needle in situ; lat.=lateral, med.=medial
Fig. 2Technique: a Ultrasound-guided ilioinguinal-iliohypogastric block; b Perifocal wound infiltration after fascial suture, injection through suture gap (arrow)
Fig. 3Inclusion procedure flowchart
Descriptive statistics (upper part), MV = mean value, SD = standard deviation, n = number. Consumption of analgesicis (lower part) for US-ILIHB and PWI group, p = significance
| US-ILIHB ( | PWI ( | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| MW | SD | n | (%) | MW | SD | n | (%) | ||
| Sex | F (n/ %) | 9 | 17.0 | 4 | 8.0 | ||||
| M (n/ %) | 44 | 83.0 | 46 | 92.0 | |||||
| ASA | I | 50 | 94.3 | 41 | 82.0 | ||||
| II | 3 | 5.7 | 9 | 18.0 | |||||
| Age (months) | 27.8 | 14.0 | 53 | 26.0 | 12.9 | 50 | |||
| Body weight (kg) | 13.0 | 3.1 | 53 | 12.5 | 2.8 | 50 | |||
| Duration of surgery (min.) | 36.3 | 14.4 | 53 | 36.7 | 13.4 | 50 | |||
| MW | SD | n | MW | SD | n | ||||
| (n)Piritramide | 0.4 | 0.6 | 53 | 0.6 | 0.8 | 50 | |||
| Σ Piritramide (mg) | 0.2 | 0.4 | 53 | 0.4 | 0.5 | 50 | |||
(n)Clonidine | 0.2 | 0.6 | 53 | 0.4 | 0.6 | 50 | |||
| Σ Clonidine (μg) | 3.0 | 6.5 | 53 | 5.9 | 8.4 | 50 | |||
Fig. 4Relative frequency of pain as a function of group and measurement times within the measurement episode (PACU, OSW, at home), 1–12 = measurement times within 24 h
Fig. 5Total relative pain frequency as a function of a the group (for all episodes), p = 0.01 b the measurement episode (for all subjects), p = < 0.001
Fig. 6Kaplan-Meier curve; Proportion of pain-free patients up to the first dose of a piritramide within the first 2 h after surgery, p = 0.003; b ibuprofen or paracetamol within the first 15 h at home, p = 0.078
Fig. 7a Percentage of children within their group who did not need analgesics; b Percentage of children within their group who received an opioid (piritramide). Grey: children in the US-ILIHB group, white: Children in the PWI group